NASDAQ · Medical - Instruments & Supplies

OraSure Technologies, Inc. (OSUR) Stock

$3.90 +2.77% NASDAQ: OSUR Healthcare

Valuation

MetricValue
Price$3.90
Market Cap$268.51M
P/E Ratio-5.75
P/B Ratio0.86
P/S Ratio2.43
EPS (TTM)$-0.94
52-Week High$4.58
52-Week Low$2.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.73%
ROA-13.63%
ROCE-15.00%
Gross Margin-59.13%
Operating Margin-59.13%
Net Margin-43.70%
Debt/Equity0.04
Current Ratio6.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$234.0M$387.0M$405.0M$186.0M$115.0M
Operating Profit$-12.0M$-5.0M$54.0M$-21.0M$-68.0M
Net Profit$-23.0M$-17.0M$54.0M$-19.0M$-69.0M
EPS$-0.32$-0.25$0.72$-0.26$-0.94
Op Margin-5.0%-1.4%13.3%-11.1%-59.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$461.0M$444.0M$483.0M$480.0M$403.0M
Total Liabilities$80.0M$80.0M$52.0M$69.0M$62.0M
Cash$117.0M$84.0M$290.0M$268.0M$199.0M
Borrowings$12.0M$13.0M$14.0M$15.0M$13.0M

Latest News

OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing MT Newswires · Jun 11, 2026 OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections GlobeNewswire · Jun 11, 2026 Is Co-Diagnostics National Security’s Next Diagnostic Pick? MarketBeat · May 28, 2026 Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist Simply Wall St. · May 20, 2026 OraSure Technologies Independent Director Acquires 195% More Stock Simply Wall St. · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-47.0M$142.0M$27.0M$0
Investing Cash Flow$-54.0M$-43.0M$56.0M$-43.0M$0
Financing Cash Flow$-2.0M$-2.0M$-2.0M$-3.0M$0
Net Cash Flow$-44.0M$-33.0M$206.0M$-23.0M$0
Free Cash Flow$-83.0M$-111.0M$131.0M$24.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.28
EV / EBITDA-2.82
FCF Yield-17.61%
Quick Ratio7.68
Interest Coverage0.00
Return 1Y22.12%
Return 3Y-10.24%
Return 5Y-57.31%

Ownership

Insiders Held6.38%
Institutions Held89.12%
Institutions Float Held95.19%
Institutional HolderSharesReport Date
Blackrock Inc.6,516,2162026-03-31
Private Management Group, Inc.5,422,1292026-03-31
Neuberger Berman Group, LLC4,361,9012026-03-31
Altai Capital Management, L.p.3,613,8362026-03-31
Vanguard Capital Management LLC3,030,8882026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATXPerspective Therapeutics, Inc. $2.66 -1.85% -1.77 $303.36M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
NAUTNautilus Biotechnology, Inc. $2.25 +23.63% -4.36 $286.32M 0.00%
NTHINeOnc Technologies Holdings, Inc. $2.78 +9.88% -1.22 $72.09M 0.00%
NYXHNyxoah SA $1.36 +0.74% -0.56 $136.10M 0.00%

About OraSure Technologies, Inc.

OraSure Technologies, Inc. is led by CEO Carrie Eglinton Manner, employs 501 people, headquartered in US, publicly traded since 1986.

OraSure Technologies, Inc. (OSUR) stock trades at $3.90 with a market capitalization of $268.51M. The stock is valued at a price-to-earnings (P/E) ratio of -5.75, price-to-book of 0.86, price-to-sales of 2.43. Over the past 52 weeks the stock has ranged between $2.08 and $4.58, and currently trades 14.8% below its 52-week high.

On profitability, OraSure Technologies, Inc. generates a return on equity (ROE) of -14.73%, return on capital employed of -15.00%, an operating margin of -59.13%, a net profit margin of -43.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides